共 64 条
[1]
Li C(2014)Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo Biotechnol J 9 652-63
[2]
Li C(2020)RPL21 siRNA Blocks Proliferation in Pancreatic Cancer Cells by Inhibiting DNA Replication and Inducing G1 Arrest and Apoptosis Front Oncol 10 1730-81
[3]
Xiang XS(2022)Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer Biochim Biophys Acta Rev Cancer 1877 188676-3
[4]
Sarantis P(2020)Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy World J Gastrointest Oncol 12 173-705
[5]
Biankin AV(2015)Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy Subtyping Pancreat Cancer Cancer Cell 28 411-6
[6]
Maitra A(2018)Targeting Treg cells in cancer immunotherapy Expert Rev Vaccines 17 697-513
[7]
Collins JM(2019)Integrating oncolytic viruses in combination cancer immunotherapy Eur J Immunol 49 1140-42
[8]
Redman JM(2018)FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy Nat Rev Immunol 18 498-86
[9]
Gulley JL(2016)Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial Oncologist 21 634-65
[10]
Tanaka A(2012)Safety and activity of anti-PD-L1 antibody in patients with advanced cancer Lancet Oncol 13 879-33